Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Absci Corporation (ABSI)

3.83   0.28 (7.89%) 05-16 01:31
Open: 3.57 Pre. Close: 3.55
High: 3.9296 Low: 3.57
Volume: 1,476,084 Market Cap: 356(M)
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.94 - 3.96 3.96 - 3.97
Low: 3.53 - 3.55 3.55 - 3.57
Close: 3.79 - 3.83 3.83 - 3.86

Technical analysis

as of: 2022-05-13 4:36:03 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 7.32     One year: 9.46
Support: Support1: 3.31    Support2: 2.75
Resistance: Resistance1: 6.27    Resistance2: 8.1
Pivot: 5.31
Moving Average: MA(5): 3.83     MA(20): 5.86
MA(100): 7.5     MA(250): 0
MACD: MACD(12,26): -1.1     Signal(9): -0.9
Stochastic oscillator: %K(14,3): 6.8     %D(3): 5.1
RSI: RSI(14): 24.7
52-week: High: 31.53  Low: 3.31
Average Vol(K): 3-Month: 608 (K)  10-Days: 677 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ABSI ] has closed above bottom band by 18.8%. Bollinger Bands are 84.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.

Headline News

Fri, 13 May 2022
Absci (NASDAQ:ABSI) Posts Quarterly Earnings Results, Misses Estimates By $0.04 EPS - Defense World

Fri, 13 May 2022
Five Things for Friday, including Dutch Bros (NYSE: BROS) and Absci (Nasdaq: ABSI) - Portland Business Journal - The Business Journals

Thu, 12 May 2022
702 Stocks Hit New Lows Thursday; Healthcare Dominates List - InvestorsObserver

Tue, 10 May 2022
Analysts' Downgrades for May 10th (ABEV, ABOS, ABSI, ADSE, AKBA, AKRO, ALCO, ALGS, ALLK, ALRM) - Defense World

Thu, 05 May 2022
Zacks Investment Research Downgrades Absci (NASDAQ:ABSI) to Sell - Defense World

Fri, 29 Apr 2022
No association between dietary magnesium intake and body composition among Iranian adults: a cross-sectional study - BMC Nutrition - BioMed Central

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 93 (M)
% Held by Insiders 4.269e+007 (%)
% Held by Institutions 31.8 (%)
Shares Short 4,350 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -6.768e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -1
Return on Assets (ttm) 554.5
Return on Equity (ttm) -18.1
Qtrly Rev. Growth 4.78e+006
Gross Profit (p.s.) -0.08
Sales Per Share 0.06
EBITDA (p.s.) -0.53
Qtrly Earnings Growth -2.1
Operating Cash Flow 0 (M)
Levered Free Cash Flow -61 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio -0.4
Price to Book value 0
Price to Sales 58.51
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 5.66e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.